Nigel is the professor of pathology at the University of California San Diego and has studied peripheral neuropathy since his undergraduate studies with one of the scientific founders of the field, David Tomlinson, in 1983. He has been involved in the preclinical/clinical development of multiple therapeutic programs and is a KOL for companies engaged in drug development. He also served as the lead preclinical contactor to the NIH NIDDK-RAID program and is a member of the executive committee of the EASD Neurodiab Study Group.